Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports. The Nifty Pharma Index dropped 1.5%, with J B Chemicals & Pharmaceuticals ...

Sun Pharmaceutical Industries Ltd. closed 9.91% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Previously, Rybelsus — an approved diabetes drug in pill form — was also used for weight loss by patients in India. Launched ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.45% to 1,683.85 Indian rupees Thursday, on what proved to be an all-around rough trading session for the stock market, with the BSE ...

The stock of the country’s largest pharmaceutical company, Sun Pharmaceutical Industries (Sun Pharma), has shed about 15 per cent from its highs over the last three months. Weak US sales trajectory, ...

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...

India's pharma giant Sun Pharma to acquire Checkpoint Therapeutics (NASDAQ:CKPT)—an immunotherapy and targeted oncology company—for an upfront cash payment of $355M. The deal involves an ...

Sun Pharma will purchase Checkpoint’s complete outstanding shares. Credit: Nils Versemann/Shutterstock. Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company ...

Novo Nordisk said patent expiry was a “natural part of the pharmaceutical product lifestyle ... Hikma launched liraglutide, a generic version of an earlier Novo Nordisk weight loss drug ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but in how she thought about food. Where the smell of hot chips in the deep ...